Switch to:
Also traded in: Brazil, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.69
AET's Cash-to-Debt is ranked lower than
68% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.61 vs. AET: 0.69 )
Ranked among companies with meaningful Cash-to-Debt only.
AET' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.42  Med: 9.19 Max: 39.76
Current: 0.69
0.42
39.76
Equity-to-Asset 0.28
AET's Equity-to-Asset is ranked lower than
74% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.38 vs. AET: 0.28 )
Ranked among companies with meaningful Equity-to-Asset only.
AET' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.06  Med: 0.21 Max: 0.3
Current: 0.28
0.06
0.3
Debt-to-Equity 0.59
AET's Debt-to-Equity is ranked higher than
56% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.64 vs. AET: 0.59 )
Ranked among companies with meaningful Debt-to-Equity only.
AET' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.13  Med: 0.23 Max: 1.16
Current: 0.59
0.13
1.16
Debt-to-EBITDA 2.21
AET's Debt-to-EBITDA is ranked lower than
59% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.82 vs. AET: 2.21 )
Ranked among companies with meaningful Debt-to-EBITDA only.
AET' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.17  Med: 1.77 Max: 3.92
Current: 2.21
1.17
3.92
Interest Coverage 8.69
AET's Interest Coverage is ranked lower than
62% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.81 vs. AET: 8.69 )
Ranked among companies with meaningful Interest Coverage only.
AET' s Interest Coverage Range Over the Past 10 Years
Min: 7.8  Med: 10.76 Max: 13.96
Current: 8.69
7.8
13.96
Piotroski F-Score: 3
Altman Z-Score: 2.14
Beneish M-Score: -2.05
WACC vs ROIC
5.36%
13.61%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 6.35
AET's Operating Margin % is ranked higher than
59% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.41 vs. AET: 6.35 )
Ranked among companies with meaningful Operating Margin % only.
AET' s Operating Margin % Range Over the Past 10 Years
Min: 5.47  Med: 7.4 Max: 10.2
Current: 6.35
5.47
10.2
Net Margin % 3.15
AET's Net Margin % is ranked lower than
56% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.64 vs. AET: 3.15 )
Ranked among companies with meaningful Net Margin % only.
AET' s Net Margin % Range Over the Past 10 Years
Min: 3.15  Med: 4.01 Max: 5.88
Current: 3.15
3.15
5.88
ROE % 12.10
AET's ROE % is ranked lower than
69% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.12 vs. AET: 12.10 )
Ranked among companies with meaningful ROE % only.
AET' s ROE % Range Over the Past 10 Years
Min: 11.38  Med: 15.41 Max: 19.85
Current: 12.1
11.38
19.85
ROA % 3.23
AET's ROA % is ranked lower than
61% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.86 vs. AET: 3.23 )
Ranked among companies with meaningful ROA % only.
AET' s ROA % Range Over the Past 10 Years
Min: 3.06  Med: 4.05 Max: 5.2
Current: 3.23
3.06
5.2
ROC (Joel Greenblatt) % 589.63
AET's ROC (Joel Greenblatt) % is ranked higher than
88% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 65.31 vs. AET: 589.63 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
AET' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 421.13  Med: 565.4 Max: 1170.02
Current: 589.63
421.13
1170.02
3-Year Revenue Growth Rate 3.80
AET's 3-Year Revenue Growth Rate is ranked lower than
77% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.60 vs. AET: 3.80 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
AET' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -15.7  Med: 5.3 Max: 22
Current: 3.8
-15.7
22
3-Year EBITDA Growth Rate -0.20
AET's 3-Year EBITDA Growth Rate is ranked lower than
80% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.30 vs. AET: -0.20 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
AET' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 2.6 Max: 76.7
Current: -0.2
0
76.7
GuruFocus has detected 6 Warning Signs with Aetna Inc AET.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» AET's 30-Y Financials

Financials (Next Earnings Date: 2018-05-02)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2017

AET Guru Trades in Q1 2017

Eaton Vance Worldwide Health Sciences Fund 191,137 sh (New)
Louis Moore Bacon 25,000 sh (+911.74%)
Steven Cohen 228,300 sh (+81.96%)
Paul Tudor Jones 16,335 sh (+73.57%)
Jana Partners 1,450,016 sh (+62.43%)
Joel Greenblatt 44,978 sh (+18.83%)
Jim Simons 3,111,482 sh (+9.45%)
Diamond Hill Capital 1,656,372 sh (+7.04%)
Chris Davis 4,163,857 sh (+5.76%)
David Dreman Sold Out
George Soros Sold Out
David Swensen Sold Out
John Burbank Sold Out
Jeff Auxier 5,307 sh (-0.17%)
Richard Pzena 154,946 sh (-0.19%)
Pioneer Investments 90,146 sh (-0.39%)
Larry Robbins 5,029,073 sh (-3.18%)
John Buckingham 82,287 sh (-6.12%)
Vanguard Health Care Fund 5,230,989 sh (-22.55%)
Ray Dalio 85,970 sh (-54.51%)
Lee Ainslie 987,480 sh (-55.71%)
Jeremy Grantham 24,877 sh (-65.28%)
» More
Q2 2017

AET Guru Trades in Q2 2017

Dodge & Cox 1,400 sh (New)
David Dreman 7,320 sh (New)
Richard Pzena 154,946 sh (unchged)
Jeff Auxier 5,307 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 191,137 sh (unchged)
Ray Dalio Sold Out
Jana Partners Sold Out
Louis Moore Bacon Sold Out
Paul Tudor Jones Sold Out
John Buckingham 81,952 sh (-0.41%)
Diamond Hill Capital 1,630,235 sh (-1.58%)
Vanguard Health Care Fund 5,101,289 sh (-2.48%)
Chris Davis 3,980,111 sh (-4.41%)
Jeremy Grantham 22,277 sh (-10.45%)
Pioneer Investments 78,035 sh (-13.43%)
Larry Robbins 3,310,469 sh (-34.17%)
Joel Greenblatt 28,625 sh (-36.36%)
Steven Cohen 128,600 sh (-43.67%)
Jim Simons 1,290,092 sh (-58.54%)
Lee Ainslie 11,470 sh (-98.84%)
» More
Q3 2017

AET Guru Trades in Q3 2017

Ray Dalio 11,904 sh (New)
Leon Cooperman 179,700 sh (New)
Paul Tudor Jones 13,663 sh (New)
George Soros 88,100 sh (New)
Caxton Associates 3,200 sh (New)
Steven Cohen 429,353 sh (+233.87%)
Joel Greenblatt 44,344 sh (+54.91%)
Lee Ainslie 14,020 sh (+22.23%)
Larry Robbins 3,794,484 sh (+14.62%)
Diamond Hill Capital 1,633,972 sh (+0.23%)
John Buckingham 82,109 sh (+0.19%)
Pioneer Investments 78,035 sh (unchged)
Jeff Auxier 5,307 sh (unchged)
Dodge & Cox 1,400 sh (unchged)
David Dreman 7,320 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 191,137 sh (unchged)
Richard Pzena Sold Out
Chris Davis 3,824,917 sh (-3.90%)
Vanguard Health Care Fund 4,646,623 sh (-8.91%)
Jim Simons 605,490 sh (-53.07%)
Jeremy Grantham 10,177 sh (-54.32%)
» More
Q4 2017

AET Guru Trades in Q4 2017

Leucadia National 163,000 sh (New)
Louis Moore Bacon 30,000 sh (New)
Daniel Loeb 1,850,000 sh (New)
John Paulson 50,000 sh (New)
Jeremy Grantham 318,700 sh (+3031.57%)
Pioneer Investments 926,948 sh (+1087.86%)
Paul Tudor Jones 109,000 sh (+697.78%)
Lee Ainslie 38,530 sh (+174.82%)
George Soros 199,000 sh (+125.88%)
Joel Greenblatt 46,880 sh (+5.72%)
Jeff Auxier 5,308 sh (+0.02%)
David Dreman 7,320 sh (unchged)
Dodge & Cox 1,400 sh (unchged)
Ray Dalio Sold Out
Jim Simons Sold Out
Leon Cooperman Sold Out
Caxton Associates Sold Out
Diamond Hill Capital 1,632,830 sh (-0.07%)
John Buckingham 78,411 sh (-4.50%)
Vanguard Health Care Fund 4,051,023 sh (-12.82%)
Chris Davis 3,255,479 sh (-14.89%)
Larry Robbins 2,869,460 sh (-24.38%)
Steven Cohen 4,200 sh (-99.02%)
Eaton Vance Worldwide Health Sciences Fund 154,756 sh (-19.03%)
» More
» Details

Insider Trades

Latest Guru Trades with NYSE:AET

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Vanguard Health Care Fund 2017-12-31 Reduce -12.82%0.2%$151.44 - $182.73 $ 175.552%4,051,023
Chris Davis 2017-12-31 Reduce -14.89%0.39%$151.44 - $182.73 $ 175.552%3,255,479
George Soros 2017-12-31 Add 125.88%0.56%$151.44 - $182.73 $ 175.552%199,000
Leucadia National 2017-12-31 New Buy2.25%$151.44 - $182.73 $ 175.552%163,000
John Paulson 2017-12-31 New Buy0.18%$151.44 - $182.73 $ 175.552%50,000
Joel Greenblatt 2017-12-31 Add 5.72%0.01%$151.44 - $182.73 $ 175.552%46,880
Leon Cooperman 2017-12-31 Sold Out 1.11%$151.44 - $182.73 $ 175.552%0
Vanguard Health Care Fund 2017-09-30 Reduce -8.91%0.15%$151.98 - $163.21 $ 175.5512%4,646,623
Chris Davis 2017-09-30 Reduce -3.90%0.1%$151.98 - $163.21 $ 175.5512%3,824,917
Leon Cooperman 2017-09-30 New Buy1.11%$151.98 - $163.21 $ 175.5512%179,700
George Soros 2017-09-30 New Buy0.42%$151.98 - $163.21 $ 175.5512%88,100
Joel Greenblatt 2017-09-30 Add 54.91%0.04%$151.98 - $163.21 $ 175.5512%44,344
Richard Pzena 2017-09-30 Sold Out 0.13%$151.98 - $163.21 $ 175.5512%0
Vanguard Health Care Fund 2017-06-30 Reduce -2.48%0.04%$127.28 - $152.98 $ 175.5524%5,101,289
Chris Davis 2017-06-30 Reduce -4.41%0.1%$127.28 - $152.98 $ 175.5524%3,980,111
Joel Greenblatt 2017-06-30 Reduce -36.36%0.03%$127.28 - $152.98 $ 175.5524%28,625
David Dreman 2017-06-30 New Buy0.61%$127.28 - $152.98 $ 175.5524%7,320
Dodge & Cox 2017-06-30 New Buy$127.28 - $152.98 $ 175.5524%1,400
Vanguard Health Care Fund 2017-03-31 Reduce -22.55%0.45%$116.71 - $134.11 $ 175.5540%5,230,989
Chris Davis 2017-03-31 Add 5.76%0.12%$116.71 - $134.11 $ 175.5540%4,163,857
Richard Pzena 2017-03-31 Reduce -0.19%$116.71 - $134.11 $ 175.5540%154,946
Joel Greenblatt 2017-03-31 Add 18.83%0.01%$116.71 - $134.11 $ 175.5540%44,978
George Soros 2017-03-31 Sold Out 0.13%$116.71 - $134.11 $ 175.5540%0
David Swensen 2017-03-31 Sold Out 0.05%$116.71 - $134.11 $ 175.5540%0
David Dreman 2017-03-31 Sold Out 0.02%$116.71 - $134.11 $ 175.5540%0
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans    NAICS: 524114    SIC: 6324
Compare:NYSE:ANTM, NYSE:CI, NAS:ESRX, NYSE:CVS, NYSE:HUM, NYSE:CNC, NYSE:WCG, NYSE:MOH, BSP:QUAL3, BSP:ODPV3, NAS:MGLN, XPAR:GDS, NAS:HIIQ, OSTO:MCOV B, ROCO:6665, ATH:IATR, ASX:ONT, TSXV:NAC, MIL:HI, OTCPK:HFRN » details
Traded in other countries:AETB34.Brazil, HE8.Germany,
Headquarter Location:USA
Aetna Inc is a diversified health care benefits company. The company offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health.

Aetna is one of the largest managed-care organizations in the U.S., with over 22 million medical members. This large member count helps the firm diversify its operating risk and has formed the basis for material competitive advantages. The firm provides health insurance services to its members through products that encompass every major insurance market--individual, group, and government sponsored. Aetna and CVS recently announced their intention to merge operations, and if approved, it would form one of the most powerful players within the healthcare space.

Top Ranked Articles about Aetna Inc

Daniel Loeb's Top 10 Holdings of 4th Quarter Third Point investor's latest buys
Daniel Loeb (Trades, Portfolio), founder of Third Point, whose returns have nearly doubled those in the S&P 500 since its 1996 inception, reported on Friday purchasing 13 stocks during the fourth quarter. Read more...
Baby Berkshire Bets on Mergers Reshaping Key Industries Leucadia National takes positions in new companies on the brink of transformation
One of the baby Berkshires is sinking its teeth into the Food Network and the Cooking Channel. Read more...
CVS Health Falls Despite Earnings Beat Company boosts pay, benefits for employees
Drugstore chain CVS Health Inc. (NYSE:CVS) reported better-than-expected fourth-quarter and full-year earnings before the opening bell on Thursday and announced wage hikes and improved benefits for employees. Read more...
Healthcare Shares Fall With Buffett in the Game Buffett is teaming up with Amazon and Chase to craft a plan to provide reasonable health care
Today’s announcement of a health care partnership between legendary investor Warren Buffett (Trades, Portfolio) and two major corporations is striking a bit of panic on Wall Street. Read more...
Barrack, Rodos & Bacine Files a Securities Class Action on Behalf of Aetna, Inc. Investors
Analysts Take Action on Health Care Stocks Eli Lilly and Abbott Labs have been downgraded while Aetna has been upgraded
Analysts are taking action on health care stocks. Read more...
Lifshitz & Miller LLP Announces Investigation of Aetna Inc., AZZ Inc., Barracuda Networks, Inc., Bill Barrett Corporation, Blackhawk Network Holdings, Inc., Capitala Finance Corp., and Ekso Bionics Holdings, Inc.
SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit In Connection With The Sale Of Aetna, Inc. (NYSE:AET)
Monteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Aetna, Inc In The District Of Connecticut

Ratios

vs
industry
vs
history
PE Ratio 30.52
AET's PE Ratio is ranked lower than
91% of the 32 Companies
in the Global Health Care Plans industry.

( Industry Median: 20.88 vs. AET: 30.52 )
Ranked among companies with meaningful PE Ratio only.
AET' s PE Ratio Range Over the Past 10 Years
Min: 5.42  Med: 12.66 Max: 45.35
Current: 30.52
5.42
45.35
Forward PE Ratio 16.86
AET's Forward PE Ratio is ranked lower than
64% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 15.24 vs. AET: 16.86 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 30.52
AET's PE Ratio without NRI is ranked lower than
91% of the 33 Companies
in the Global Health Care Plans industry.

( Industry Median: 20.88 vs. AET: 30.52 )
Ranked among companies with meaningful PE Ratio without NRI only.
AET' s PE Ratio without NRI Range Over the Past 10 Years
Min: 5.42  Med: 12.66 Max: 45.35
Current: 30.52
5.42
45.35
PB Ratio 3.68
AET's PB Ratio is ranked lower than
57% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.45 vs. AET: 3.68 )
Ranked among companies with meaningful PB Ratio only.
AET' s PB Ratio Range Over the Past 10 Years
Min: 0.88  Med: 1.84 Max: 4.04
Current: 3.68
0.88
4.04
PS Ratio 0.97
AET's PS Ratio is ranked higher than
50% of the 30 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.98 vs. AET: 0.97 )
Ranked among companies with meaningful PS Ratio only.
AET' s PS Ratio Range Over the Past 10 Years
Min: 0.29  Med: 0.54 Max: 1.13
Current: 0.97
0.29
1.13
EV-to-EBIT 17.58
AET's EV-to-EBIT is ranked lower than
84% of the 49 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.91 vs. AET: 17.58 )
Ranked among companies with meaningful EV-to-EBIT only.
AET' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.9  Med: 7.6 Max: 19.4
Current: 17.58
3.9
19.4
EV-to-EBITDA 14.58
AET's EV-to-EBITDA is ranked lower than
88% of the 49 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.15 vs. AET: 14.58 )
Ranked among companies with meaningful EV-to-EBITDA only.
AET' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.5  Med: 6.6 Max: 16.1
Current: 14.58
3.5
16.1
EV-to-Revenue 0.99
AET's EV-to-Revenue is ranked lower than
59% of the 51 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.69 vs. AET: 0.99 )
Ranked among companies with meaningful EV-to-Revenue only.
AET' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.3  Med: 0.6 Max: 1.1
Current: 0.99
0.3
1.1
PEG Ratio 4.11
AET's PEG Ratio is ranked lower than
85% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.32 vs. AET: 4.11 )
Ranked among companies with meaningful PEG Ratio only.
AET' s PEG Ratio Range Over the Past 10 Years
Min: 0.36  Med: 1.01 Max: 6.51
Current: 4.11
0.36
6.51
Shiller PE Ratio 33.20
AET's Shiller PE Ratio is ranked lower than
65% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 31.74 vs. AET: 33.20 )
Ranked among companies with meaningful Shiller PE Ratio only.
AET' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.36  Med: 19.49 Max: 47.23
Current: 33.2
10.36
47.23
Current Ratio 0.92
AET's Current Ratio is ranked lower than
76% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.29 vs. AET: 0.92 )
Ranked among companies with meaningful Current Ratio only.
AET' s Current Ratio Range Over the Past 10 Years
Min: 0.65  Med: 0.87 Max: 2.78
Current: 0.92
0.65
2.78
Quick Ratio 0.92
AET's Quick Ratio is ranked lower than
72% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.29 vs. AET: 0.92 )
Ranked among companies with meaningful Quick Ratio only.
AET' s Quick Ratio Range Over the Past 10 Years
Min: 0.65  Med: 0.87 Max: 2.78
Current: 0.92
0.65
2.78
Days Sales Outstanding 30.58
AET's Days Sales Outstanding is ranked higher than
50% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 30.58 vs. AET: 30.58 )
Ranked among companies with meaningful Days Sales Outstanding only.
AET' s Days Sales Outstanding Range Over the Past 10 Years
Min: 16.34  Med: 24.57 Max: 30.58
Current: 30.58
16.34
30.58
Days Payable 47.56
AET's Days Payable is ranked higher than
60% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 47.30 vs. AET: 47.56 )
Ranked among companies with meaningful Days Payable only.
AET' s Days Payable Range Over the Past 10 Years
Min: 38.83  Med: 47.33 Max: 52.51
Current: 47.56
38.83
52.51

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.13
AET's Dividend Yield % is ranked lower than
56% of the 32 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.03 vs. AET: 1.13 )
Ranked among companies with meaningful Dividend Yield % only.
AET' s Dividend Yield % Range Over the Past 10 Years
Min: 0.07  Med: 0.83 Max: 1.77
Current: 1.13
0.07
1.77
Dividend Payout Ratio 0.28
AET's Dividend Payout Ratio is ranked higher than
69% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 9999.00 vs. AET: 0.28 )
Ranked among companies with meaningful Dividend Payout Ratio only.
AET' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.01  Med: 0.15 Max: 0.31
Current: 0.28
0.01
0.31
3-Year Dividend Growth Rate 24.80
AET's 3-Year Dividend Growth Rate is ranked higher than
75% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.40 vs. AET: 24.80 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
AET' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 171.4
Current: 24.8
0
171.4
Forward Dividend Yield % 1.14
AET's Forward Dividend Yield % is ranked lower than
85% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.62 vs. AET: 1.14 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 2.42
AET's 5-Year Yield-on-Cost % is ranked lower than
66% of the 38 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.83 vs. AET: 2.42 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
AET' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.15  Med: 1.78 Max: 3.8
Current: 2.42
0.15
3.8
3-Year Average Share Buyback Ratio 2.30
AET's 3-Year Average Share Buyback Ratio is ranked higher than
75% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: -0.50 vs. AET: 2.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
AET' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -10.2  Med: 0.6 Max: 8.8
Current: 2.3
-10.2
8.8

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 3.67
AET's Price-to-Tangible-Book is ranked higher than
89% of the 38 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.55 vs. AET: 3.67 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
AET' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.55  Med: 3.77 Max: 16.17
Current: 3.67
0.55
16.17
Price-to-Intrinsic-Value-Projected-FCF 1.58
AET's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
78% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.14 vs. AET: 1.58 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
AET' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.32  Med: 0.63 Max: 1.99
Current: 1.58
0.32
1.99
Price-to-Intrinsic-Value-DCF (Earnings Based) 2.28
AET's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
88% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.22 vs. AET: 2.28 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
AET' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.39  Med: 1.03 Max: 2.34
Current: 2.28
0.39
2.34
Price-to-Median-PS-Value 1.80
AET's Price-to-Median-PS-Value is ranked lower than
82% of the 39 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.20 vs. AET: 1.80 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
AET' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.35  Med: 0.83 Max: 2.35
Current: 1.8
0.35
2.35
Price-to-Peter-Lynch-Fair-Value 5.44
AET's Price-to-Peter-Lynch-Fair-Value is ranked lower than
100% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.97 vs. AET: 5.44 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
AET' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.24  Med: 0.83 Max: 5.59
Current: 5.44
0.24
5.59
Price-to-Graham-Number 2.23
AET's Price-to-Graham-Number is ranked higher than
80% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.87 vs. AET: 2.23 )
Ranked among companies with meaningful Price-to-Graham-Number only.
AET' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.45  Med: 1.55 Max: 3.35
Current: 2.23
0.45
3.35
Earnings Yield (Greenblatt) % 5.69
AET's Earnings Yield (Greenblatt) % is ranked lower than
80% of the 51 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.75 vs. AET: 5.69 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
AET' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 5.2  Med: 13.2 Max: 25.4
Current: 5.69
5.2
25.4
Forward Rate of Return (Yacktman) % 9.04
AET's Forward Rate of Return (Yacktman) % is ranked lower than
75% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.08 vs. AET: 9.04 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
AET' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 6  Med: 19.4 Max: 31.6
Current: 9.04
6
31.6

More Statistics

Revenue (TTM) (Mil) $60,535.00
EPS (TTM) $ 5.75
Beta0.57
Short Percentage of Float1.27%
52-Week Range $124.84 - 194.40
Shares Outstanding (Mil)326.17

Analyst Estimate

Dec18 Dec19 Dec20
Revenue (Mil $) 61,305 64,136 68,532
EBIT (Mil $) 4,603 5,705 6,193
EBITDA (Mil $) 5,069 5,439
EPS ($) 10.64 12.26 13.00
EPS without NRI ($) 10.64 12.26 13.00
EPS Growth Rate
(Future 3Y To 5Y Estimate)
16.11%
Dividends per Share ($) 1.52 2.00 2.00

Piotroski F-Score Details

Piotroski F-Score: 33
Positive ROAY
Positive CFROAN
Higher ROA yoyN
CFROA > ROAN
Lower Leverage yoyY
Higher Current Ratio yoyN
Less Shares Outstanding yoyY
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}